Weekly hormone shot shows promise for Long-Term adult treatment

NCT ID NCT05171855

Summary

This study followed adults with growth hormone deficiency who had already completed a previous trial. It aimed to see if a weekly injection of the hormone lonapegsomatropin was safe and effective for long-term use. Researchers tracked side effects and measured changes in body fat and muscle mass over a year.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADULT GROWTH HORMONE DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Ascendis Pharma Investigational Site

    Phoenix, Arizona, 85048, United States

  • Ascendis Pharma Investigational Site

    Torrance, California, 90509, United States

  • Ascendis Pharma Investigational Site

    Chicago, Illinois, 60611, United States

  • Ascendis Pharma Investigational Site

    Indianapolis, Indiana, 46202, United States

  • Ascendis Pharma Investigational Site

    Boston, Massachusetts, 02114, United States

  • Ascendis Pharma Investigational Site

    Dearborn, Michigan, 48126, United States

  • Ascendis Pharma Investigational Site

    Rochester, Minnesota, 55905, United States

  • Ascendis Pharma Investigational Site

    St Louis, Missouri, 63110, United States

  • Ascendis Pharma Investigational Site

    Las Vegas, Nevada, 89148, United States

  • Ascendis Pharma Investigational Site

    Reno, Nevada, 89511, United States

  • Ascendis Pharma Investigational Site

    New York, New York, 10017, United States

  • Ascendis Pharma Investigational Site

    Portland, Oregon, 97239, United States

  • Ascendis Pharma Investigational Site

    Dallas, Texas, 75390, United States

  • Ascendis Pharma Investigational Site

    San Antonio, Texas, 78232, United States

  • Ascendis Pharma Investigational Site

    Seattle, Washington, 98108, United States

  • Ascendis Pharma Investigational Site

    Yerevan, 0075, Armenia

  • Ascendis Pharma Investigational Site

    Saint Leonards, New South Wales, 2065, Australia

  • Ascendis Pharma Investigational Site

    Sydney, New South Wales, 2109, Australia

  • Ascendis Pharma Investigational Site

    Box Hill, Victoria, 3128, Australia

  • Ascendis Pharma Investigational Site

    Fitzroy, Victoria, 3065, Australia

  • Ascendis Pharma Investigational Site

    Parkville, Victoria, 3050, Australia

  • Ascendis Pharma Investigational Site

    Perth, Western Australia, 6009, Australia

  • Ascendis Pharma Investigational Site

    Halifax, Nova Scotia, B3H 1V7, Canada

  • Ascendis Pharma Investigational Site

    Lyon, 69677, France

  • Ascendis Pharma Investigational Site

    Marseille, 13385, France

  • Ascendis Pharma Investigational Site

    Nantes, 44093, France

  • Ascendis Pharma Investigational Site

    Tbilisi, 0144, Georgia

  • Ascendis Pharma Investigational Site

    Tbilisi, 0159, Georgia

  • Ascendis Pharma Investigational Site

    München, 80336, Germany

  • Ascendis Pharma Investigational Site

    Athens, 11527, Greece

  • Ascendis Pharma Investigational Site

    Thessaloniki, 54636, Greece

  • Ascendis Pharma Investigational Site

    Haifa, 31048, Israel

  • Ascendis Pharma Investigational Site

    Petah Tikva, 4941480, Israel

  • Ascendis Pharma Investigational Site

    Tel Aviv, 6423906, Israel

  • Ascendis Pharma Investigational Site

    Genova, 16132, Italy

  • Ascendis Pharma Investigational Site

    Rome, 00161, Italy

  • Ascendis Pharma Investigational Site

    Rome, 00168, Italy

  • Ascendis Pharma Investigational Site

    Kobe, Hyōgo, 650-0047, Japan

  • Ascendis Pharma Investigational Site

    Kawasaki, Kanagawa, 216-8511, Japan

  • Ascendis Pharma Investigational Site

    Yokohama, Kanagawa, 222-0036, Japan

  • Ascendis Pharma Investigational Site

    Chiba, 260-8677, Japan

  • Ascendis Pharma Investigational Site

    Fukuoka, 812-8582, Japan

  • Ascendis Pharma Investigational Site

    Ishikawa, 920-0293, Japan

  • Ascendis Pharma Investigational Site

    Kagoshima, 890-8520, Japan

  • Ascendis Pharma Investigational Site

    Kawasaki, 210-0024, Japan

  • Ascendis Pharma Investigational Site

    Kawasaki, 211-8533, Japan

  • Ascendis Pharma Investigational Site

    Kitakyushu, 807-8555, Japan

  • Ascendis Pharma Investigational Site

    Matsumoto, 390-8510, Japan

  • Ascendis Pharma Investigational Site

    Miyakojima, 534-0021, Japan

  • Ascendis Pharma Investigational Site

    Nagakute, 480-1195, Japan

  • Ascendis Pharma Investigational Site

    Nara, 634-8522, Japan

  • Ascendis Pharma Investigational Site

    Okayama, 700-8558, Japan

  • Ascendis Pharma Investigational Site

    Osaka, 550-0006, Japan

  • Ascendis Pharma Investigational Site

    Shizuoka, 422-8527, Japan

  • Ascendis Pharma Investigational Site

    Suita, 565-0871, Japan

  • Ascendis Pharma Investigational Site

    Yamagata, 990-9585, Japan

  • Ascendis Pharma Investigational Site

    Yokohama, 236-0004, Japan

  • Ascendis Pharma Investigational Site

    George Town, 10450, Malaysia

  • Ascendis Pharma Investigational Site

    Malacca, 75400, Malaysia

  • Ascendis Pharma Investigational Site

    Putrajaya, 62250, Malaysia

  • Ascendis Pharma Investigational Site

    Krakow, 31-501, Poland

  • Ascendis Pharma Investigational Site

    Lodz, 93-338, Poland

  • Ascendis Pharma Investigational Site

    Warsaw, 03-242, Poland

  • Ascendis Pharma Investigational Site

    Wroclaw, 50-367, Poland

  • Ascendis Pharma Investigational Site

    Bucharest, 11868, Romania

  • Ascendis Pharma Investigational Site

    Iași, 700106, Romania

  • Ascendis Pharma Investigational Site

    Belgrade, 11000, Serbia

  • Ascendis Pharma Investigational Site

    Bratislava, 82606, Slovakia

  • Ascendis Pharma Investigational Site

    Ľubochňa, 3491, Slovakia

  • Ascendis Pharma Investigational Site

    Soeul, 06591, South Korea

  • Ascendis Pharma Investigational Site

    Alicante, 3010, Spain

  • Ascendis Pharma Investigational Site

    Barcelona, 8035, Spain

  • Ascendis Pharma Investigational Site

    Barcelona, 8041, Spain

  • Ascendis Pharma Investigational Site

    Seville, 41013, Spain

  • Ascendis Pharma Investigational Site

    Ankara, 06560, Turkey (Türkiye)

  • Ascendis Pharma Investigational Site

    Antalya, 07070, Turkey (Türkiye)

  • Ascendis Pharma Investigational Site

    Aydin, 09010, Turkey (Türkiye)

  • Ascendis Pharma Investigational Site

    İzmit, 41001, Turkey (Türkiye)

  • Ascendis Pharma Investigational Site

    Kayseri, 38039, Turkey (Türkiye)

  • Ascendis Pharma Investigational Site

    Ivano-Frankivsk, 76008, Ukraine

  • Ascendis Pharma Investigational Site

    Kyiv, 03115, Ukraine

  • Ascendis Pharma Investigational Site

    Kyiv, 04001, Ukraine

  • Ascendis Pharma Investigational Site

    Kyiv, 04114, Ukraine

  • Ascendis Pharma Investigational Site

    Vinnytsia, 21010, Ukraine

  • Ascendis Pharma Investigational Site

    Leeds, LS9 7TF, United Kingdom

Conditions

Explore the condition pages connected to this study.